Synthesis and in vitro antiproliferative and antibacterial activity of new thiazolidine-2,4-dione derivatives

References

• Stewart BW, Wild CP. World Cancer Report 2014. Available from: http://www.who.int/cancer/publications/WRC_2014/en/
   Google Scholar
• Asati V, Mahapatra DK, Bharti SK. Thiazolidine-2,4-diones as multi-targeted scaffold in medicinal chemistry: potential anticancer agents. Eur J Med Chem 2014;87:814–33.
   PubMed Web of Science ®Google Scholar
• Patil V, Tilekar K, Mehendale-Munj S, et al. Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2,4-thiazolidinedione derivatives. Eur J Med Chem 2010;45:4539–44.
   PubMed Web of Science ®Google Scholar
• Havrylyuk DYa, Lesyk RB, Zimenkovsky BS, Pachovsky VYu. Synthesis and anticancer studying of 4-(2,4-thiazolidinedione-5-acetoxy)benzylidenehydrazones of benzazol-2-thioacetic acids. Farm Zh (Kiev) 2006;2:53–8.
   Google Scholar
• Havrylyuk D, Zimenkovsky B, Vasylenko O, et al. Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones. Eur J Med Chem 2013;66:228–37.
   PubMed Web of Science ®Google Scholar
• Alegaon SG, Alagawadi KR. New thiazolidinedione-5-acetic acid amide derivatives: synthesis, characterization and investigation of antimicrobial and cytotoxic properties. Med Chem Res 2012;21:816–24.
   Web of Science ®Google Scholar
• Chadha N, Bahia MS, Kaur M, Silakari O. Thiazolidine-2,4-dione derivatives: programmed chemical weapons for key protein targets of various pathological conditions. Bioorg Med Chem 2015;23:2953–74.
   PubMed Web of Science ®Google Scholar
• Jain VS, Vora DK, Ramaa CS. Thiazolidine-2,4-diones: progress towards multifarious applications. Bioorg Med Chem 2013;21:1599–620.
   PubMed Web of Science ®Google Scholar
• Rakowitz D, Maccari R, Ottana R, Vigorita MG. In vitro aldose reductase inhibitory activity of 5-benzyl-2,4-thiazolidinediones. Bioorg Med Chem 2006;14:567–74.
   PubMed Web of Science ®Google Scholar
• Aneja DK, Lohan P, Arora S, et al. Synthesis of new pyrazolyl-2, 4-thiazolidinediones as antibacterial and antifungal agents. Org Med Chem Lett 2011;1:15.
   PubMedGoogle Scholar
• Bozdağ-Dündar O, Özgen Ö, Menteşe A, et al. Synthesis and antimicrobial activity of some new thiazolyl thiazolidine-2,4-dione derivatives. Bioorg Med Chem 2007;15:6012–7.
   PubMed Web of Science ®Google Scholar
• Heerding DA, Christmann LT, Clark TJ, et al. New benzylidenethiazolidinediones as antibacterial agents. Bioorg Med Chem Lett 2003;13:3771–3.
   PubMed Web of Science ®Google Scholar
• Zimenkovskii BS, Kutsyk RV, Lesyk RB, et al. Synthesis and antimicrobial activity of 2,4-dioxothiazolidine-5-acetic acid amides. Pharm Chem J 2006;40:303–6.
   Google Scholar
• Pattan S, Kedar M, Pattan J, et al. Synthesis and evaluation of some novel 2,4-thiazolidinedione derivatives for antibacterial, antitubercular and antidiabetic activities. Indian J Chem 2012;51B:1421–5.
   Google Scholar
• Ceriello A. Thiazolidinediones as anti-inflammatory and anti-atherogenic agents. Diabetes Metab Res Rev 2008;24:14–26.
   PubMed Web of Science ®Google Scholar
• Reed JC, Pellecchia M. Apoptosis-based therapies for hematologic malignancies. Blood 2005;106:408–18.
   PubMed Web of Science ®Google Scholar
• Cai SX, Nguyen B, Jia S, et al. Discovery of substituted N-phenyl nicotinamides as potent inducers of apoptosis using a cell- and caspase-based high throughput screening assay. J Med Chem 2003;46:2474–81.
   PubMed Web of Science ®Google Scholar
• Hu K, Yang Z-H, Pan S-S, et al. Synthesis and antitumor activity of liquiritigenin thiosemicarbazone derivatives. Eur J Med Chem 2010;45:3453–8.
   PubMed Web of Science ®Google Scholar
• Krishnan K, Prathiba K, Jayaprakash V, et al. Synthesis and ribonucleotide reductase inhibitory activity of thiosemicarbazones. Bioorg Med Chem Lett 2008;18:6248–50.
   PubMed Web of Science ®Google Scholar
• Patel DH, Divatia SM, Clercq E. Synthesis of some novel thiosemicarbazone derivatives having anticancer, anti-HIV as well as antibacterial activity. Indian J Chem 2013;44:535–45.
   Google Scholar
• Cui Z, Li Y, Ling Y, et al. New class of potent antitumor acylhydrazone derivatives containing furan. Eur J Med Chem 2010;45:5576–84.
   PubMed Web of Science ®Google Scholar
• Rodrigues FAR, Oliveira ACA, Cavalcanti BC, et al. Biological evaluation of isoniazid derivatives as an anticancer class. Sci Pharm 2014;82:21–8.
   PubMedGoogle Scholar
• Yu X, Shi L, Ke S. Acylhydrazone derivatives as potential anticancer agents: synthesis, bio-evaluation and mechanism of action. Bioorg Med Chem Lett 2015;25:5772–6.
   PubMed Web of Science ®Google Scholar
• Naveen Kumar HS, Parumasivam T, Jumaat F, et al. Synthesis and evaluation of isonicotinoyl hydrazone derivatives as antimycobacterial and anticancer agents. Med Chem Res 2014;23:269–79.
   Web of Science ®Google Scholar
• Przekora A, Czechowska J, Pijocha D, et al. Do novel cement-type biomaterials reveal ion reactivity that affects cell viability in vitro? Cent Eur J Biol 2014;9:277–89.
   Google Scholar
• Clinical Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard M7 – A10. Wayne, PA; 2009.
   Google Scholar
• Lesyk RB, Zimenkovsky BS, Golota SM, Leb'yak MM. Synthesis of 2,4-dioxothiazolidine-5-acetic acid and its amides – perspective synthons for obtaining combinatorial libraries of biologically active substances. Farm Zh (Kiev) 2001;5:57–62.
   Google Scholar
• Deghenghi R, Daneault G. Orotic acid and its analogues: part II. On the alkaline rearrangement of 5-carboxymethylidenehydantoin. Can J Chem 1960;38:1255–60.
   Web of Science ®Google Scholar
• Lesyk RB, Zimenkovsky BS. Synthesis of potential biologically active substances on the base of 5-carboxymethylidene-2,4-thiazolidinedione. Farm Zh (Kiev) 2002;4:64–8.
   Google Scholar